SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status.
Daley BR, Vieira HM, Rao C, Hughes JM, Beckley ZM, Huisman DH, Chatterjee D, Sealover NE, Cox K, Askew JW, et al. Proc Natl Acad Sci U S A. 2023 Nov 21; 120(47):e2313137120. Epub 2023 Nov 16.